Navigation Links
The MedZilla Report for July, 2009 - Health Care Creates 20,000 More Jobs As Economy Hits Insurers
Date:8/12/2009

Health care jobs continue to be both created and lost each month, though the average of new jobs in the industry remains at 20,000 monthly, and health care has one of the the lowest unemployment rates of any field in the U.S. However, companies ancillary to health care, such as insurers, are feeling the economic pinch more and more.

(Vocus) August 12, 2009 -- There is a dichotomy between simultaneous job creation and job elimination in health care, and other fields as well. Those seeking new jobs in that industry are used to seeing layoffs alongside reports that jobs remain available and the field in fact continues to grow. According to the Bureau of Labor Statistics, health care employment continued to grow as it has done for the first half of 2009, with about 20,000 new jobs created in July. This remains 10,000 below the average monthly job creation number for 2008, but it is still a very positive statistic. Also, the unemployment rate within the health care field is 6.1 percent – the lowest rate among all job classes measured by the Bureau except government workers and the self-employed.

The declining U.S. economy has begun causing layoffs in areas not traditionally associated with each other. One of those is in insurance. When companies try to cut costs, employee benefits are generally part of the mix. For example, when GM and Chrysler cut their dental coverage, more than 50 people at one dental insurer were affected. Blue Cross and Blue Shield of Alabama cited similar troubles when they cut more than 150 people last month. Other services are also being eliminated – leading to job losses – including social services agencies such as the Association for Individual Development in Aurora, Ill., which served 1,100 persons with disabilities.

Last month, the

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related biology technology :

1. The MedZilla Report: June 2009 Employment Outlook for Biotech/Pharma/Health
2. The MedZilla Report: May 2009 Employment Outlook for Biotech/Pharma/Health
3. The MedZilla Report: April 2009 Employment Outlook for Biotech/Pharma/Health
4. The MedZilla Report: March 2009 Employment Outlook for Biotech/Pharma/Health
5. The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health
6. The MedZilla Report: October 2008 Employment Outlook for Biotech/Pharma/Health
7. The MedZilla Report: September 2008 Employment Outlook for Biotech/Pharma/Health
8. Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results
9. Dendreon Reports Second Quarter 2009 Financial Results
10. AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results
11. Imagenetix, Inc. Reports First Quarter 2010 Results

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The MedZilla Report for July, 2009 - Health Care Creates 20,000 More Jobs As Economy Hits Insurers
The MedZilla Report for July, 2009 - Health Care Creates 20,000 More Jobs As Economy Hits Insurers
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in Oc...consistent growth during the U.S. recession. Howev...ble, and health systems are coming closer to havin...st administrators. , (Voc...ntinued growing in October despite the shedding of...
(Date:11/24/2009)...I, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceutical...ice (PTO) has allowed the patent application for,i..., NOD technology is a highly efficient ap...o-adhesive nano-particles to enable oral delivery ... technology is a platform technology,that can be a...
(Date:11/24/2009)...HAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolaxy...istration (SFDA) has approved the,investigational ...oject,(Nodlin), an innovative insulin formulation ...y to initiate its first phase I clinical study. ,...high blood glucose and poor,metabolism. The compli...
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
... CITY, New Jersey, November 26, Rosetta Genomics (...third quarter financial results on December 5, 200...will host a conference call with a,simultaneous we...Friday,December 5. , To access the live conf...al 1-866-966-5335; international participants may ...
...E, Nov. 26 Spectrum,Pharmaceuticals, Inc. (Nasdaq...CTIC )(MTA: CTIC) announced today they have entere...nture, RIT Oncology LLC, to commercialize and,deve... United States.,ZEVALIN, a radioimmunotherapeutic ...by Cell Therapeutics, Inc. (CTI) for the treatment...
...Equels, President and Managing,Director of the Equ...ectors,for Hemispherx BioPharma, Inc. (Amex: HEB... engaged in the manufacture and clinical developme... and immune-based disorders. , Equels, legal...r emphasis,on civil racketeering, business torts a...
Other Biology Technology:Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results 2Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 2Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 3Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 4Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 5Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 6Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 7Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug 8Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 2Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors 3
(Date:11/24/2009)...eries from collapsing have been true life-savers. ...eeded -- once the arteries are strengthened, they ...ice but to leave them in place. , Prof. Meital Z...omedical Engineering has developed a new patent-pe...,re needed, then dissolves. , "Our new composite...
(Date:11/24/2009)...secrets of the earth,s history locked in its icy d...tle information on the environments that have been.... Now, a team of researchers from nine institution...$10 million dollars by the National Science Founda...rally. These scientists will drill through the Wes...
(Date:11/23/2009)...vidence that the "synergistic" effect of early-lif...on and indoor endotoxin causes more harm to develo... , Environmental health scientists at the Univer...hown that children exposed to both high levels of ...ing early life are six times more likely to experi...
Breaking Biology News(10 mins):A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A Milestone of Opportunity for VNUS Medical Technologies 48130 1A Milestone of Opportunity for VNUS Medical Technologies 48130 2A Milestone of Opportunity for VNUS Medical Technologies 48130 3Providence Health 26 Services Increases Revenue by 2435 Million Using Concuity ClearContracts 12502 1Providence Health 26 Services Increases Revenue by 2435 Million Using Concuity ClearContracts 12502 2Providence Health 26 Services Increases Revenue by 2435 Million Using Concuity ClearContracts 12502 3Forterus Inc Announces Free Outpatient Treatment to Military Veterans Back from War Zones 48129 1Forterus Inc Announces Free Outpatient Treatment to Military Veterans Back from War Zones 48129 2
...unisia, supported by the European Commission, high... health in countries bordering the Mediterranean S...rtance of Euro-Mediterranean partnerships in order...e sciences ?in particular following the mapping of...rove scientific knowledge and approaches to improv...
... radiotherapy, on a cellular scale. Antibodies cou..., bind to and kill cancerous cells. Provided that ...ce between normal and cancerous cells; this is not... for lymphoma that takes a fraction of the time of...caused tumors to shrink in 95 percent of patients,...
...called CD14 binds to substances liberated from the...nisms. In a report published in the Journal of Bio...heir elucidation of three-dimensional structure of...d to certain bacterial products. , The research ap...ssue of the Journal of Biological Chemistry, an Am...
Other Biology News:Measuring the impact of post-genomics on Mediterranean populations 2New Treatment Rivals Chemotherapy For Lymphoma, Study Finds 2New Treatment Rivals Chemotherapy For Lymphoma, Study Finds 3Scientists solve structure of key protein in innate immune response 2
Stirbar, Trans-Blot Plus cell from Bio-Rad
Super Cooling Coil, Trans-Blot cell from Bio-Rad
Criterion Staining and Blotting Trays, with lids, 12 from Bio-Rad
...ting a wide range of next-generation features into...andard for flexible laboratory solutions. It puts ...ng, dilution, dispensing, and integrations into a...exible as it is efficient and economical. The Biom...
Biology Products: